SCHEMBL23093086

SCHEMBL23093086

Cc1cc(CCCO)ccc1NC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ CYP4A11 Q02928 2/20 0.41
▸ KCNQ4 P56696 3/20 0.41
▸ KCNQ5 Q9NR82 3/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ NR1H4 Q96RI1 1/20 0.41
▸ NR1H2 P55055 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CYP4F2 P78329 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ LCK P06239 1/20 0.39
▸ CYP17A1 P05093 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ CISD2 Q8N5K1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23093142 0.90 SMN1; SMN2 (0.47) SMN1; SMN2KCNQ4KCNQ5PPARANR1H4
SCHEMBL23092995 0.88 SMN1; SMN2 (0.43) SMN1; SMN2KCNQ4KCNQ5NR1H4TP53
SCHEMBL23092969 0.88 SMN1; SMN2 (0.46) SMN1; SMN2KCNQ4KCNQ5PPARATP53
SCHEMBL5162892 0.86 SMN1; SMN2 (0.48) SMN1; SMN2KCNQ4KCNQ5NR1H4MEN1
SCHEMBL19966996 0.85 MAPT (0.44) CYP4A11KCNQ4KCNQ5PPARANR1H2
SCHEMBL23093001 0.83 KCNQ4 (0.39) SMN1; SMN2KCNQ4KCNQ5NR1H4TP53
SCHEMBL23093006 0.83 SMN1; SMN2 (0.41) SMN1; SMN2KCNQ4KCNQ5NR1H4TP53
SCHEMBL6676620 0.82 SMN1; SMN2 (0.47) SMN1; SMN2KCNQ4KCNQ5PPARANR1H4
SCHEMBL23093237 0.82 CYP4A11 (0.45) SMN1; SMN2CYP4A11PPARANR1H4TP53
SCHEMBL6404856 0.79 CYP17A1 (0.56) CYP4A11PPARANR1H2CYP4F2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021050547-A1 MITOCHONDRIAL COMPLEX I INHIBITORS AND METHODS OF USE Sanford Burnham Prebys Medical Discovery Institute (US) 2021-03-18 — — WO disclosed
Send feedback